Corium International, Inc.

Corium International, Inc. is a leader in applying advanced transdermal delivery systems and related technologies to address unmet medical needs. We have developed two highly differentiated state of the art transdermal technologies:
  • MicroCor®, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines large molecules that require active transport through the skin
  • Corplex™, a novel adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver
With a team that includes the innovators of many of the market-leading transdermal products, Corium combines great technologies with a strong track record of successfully designing, developing and producing therapeutic products.

Corium News

Date Title and Summary View
February 8, 2016 MENLO PARK, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results from operations for the first fiscal quarter ended December 31, ...
February 3, 2016 Demonstrates Sustained Delivery, Acceptable Skin Tolerability, and Pharmacokinetic Profile to Support the Feasibility of Once-Weekly Dosing Webcast and Conference Call Today at 5:00 p.m. ET (2:00 p.m. PT) MENLO PARK, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical...

Copyright ©2006-2015 Corium International, Inc.